Sermorelin alone patients new to peptide therapy, those focused on sleep and general anti-aging, patients who prefer the simplest daily protocol, and those who value the historically FDA-approved molecule status
The peptide space is unfortunately filled with providers cutting corners, resulting in under-dosed products, incorrect sequences, orworst of alldangerous contaminants
The treatment is generally well-tolerated, but like all medications, it can have side effects, which may include: Med spas offering Semaglutide ensure that these treatments are administered under strict medical supervision, with regular follow-ups to manage any adverse effects effectively
10 Adverse events 5% in SUSTAIN 5 8,10 AEs occurring in 5% of participants treated with Ozempic in SUSTAIN 5 Incidence of severe hypoglycemia was 1.5% across all placebo-controlled trials 1 Incidence of severe hypoglycemia or blood glucose-confirmed hypoglycemia (% of patients) was 8,10 : 8.3% with Ozempic 0.5 mg + basal insulin MET 10.7% with Ozempic 1 mg + basal insulin MET 5.3% with placebo + basal insulin MET Patients receiving Ozempic in combination with an insulin secretagogue (eg, sulfonylurea) or insulin may have an increased risk of hypoglycemia, including severe hypoglycemia 1 ADA=American Diabetes Association
